August 25 2010 12:00 AM EST
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2026 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
The human AIDS viruses (HIV-1 and HIV-2) originated as viruses of apes and monkeys, respectively, yet little is known about whether or how these invaders adapted to the new genetic "environment" encountered in humans. One group of host genes, collectively known as restriction factors, is thought to influence the ability of such viruses to move between different primate species.
A study conducted by Andrea Kirmaier and Welkin Johnson of Harvard Medical School, together with Vanessa Hirsch of the National Institutes of Health, provides direct evidence in apes and monkeys of a restriction factor gene called TRIM5 acting as a genetic barrier to cross-species transmission of a primate immunodeficiency virus related to HIV-2. The findings will publish next week in the online, open access journal PLoS Biology.
The primate immunodeficiency viruses include HIV-1 and HIV-2 as well as the numerous simian immunodeficiency viruses found among African apes and monkeys. The distribution of SIVs among their natural hosts reflects a long history of viruses jumping between species, including the very recent invasions of humans by SIVs from chimpanzees, giving rise to HIV-1, and sooty mangabey monkeys, giving rise to HIV-2. SIV from sooty mangabeys also jumped into Asian rhesus monkeys where, like HIV-1 and HIV-2 in humans, it causes AIDS.
Scientists believe that the movement of viral pathogens between hosts ultimately drove the evolution of certain genes, called restriction factors, as protection against such events. Expression of one such gene, TRIM5, renders cultured cells resistant to infection by retroviruses (including human retroviruses like HIV-1 and HIV-2) in the laboratory. The study by Kirmaier and colleagues now confirms the ability of TRIM5 to suppress cross-species transmission of SIV in vivo.
From our Sponsors
Most Popular
Newly diagnosed with HIV? Advocates share their best advice for seeking treatment
April 29 2026 3:32 PM
Plus: Featured Video
Latest Stories
A new HIV diagnosis doesn't have to be nerve-wracking. Advocates share their advice
July 30 2026 12:01 PM
How to find an HIV-competent healthcare provider, according to advocates
May 19 2026 4:55 PM
Can a single infusion of immune cells suppress HIV for years?
May 11 2026 11:39 AM
National HIV advocacy group's CEO rejects claims of crisis
April 21 2026 5:14 PM
Beyond awareness: How youth leadership is reshaping the HIV response
April 10 2026 9:12 AM
Saving public health? AIDS United's new CEO has a plan
March 23 2026 9:48 AM
Struggling with daily HIV meds? Monthly shots may be the answer
March 20 2026 7:12 AM
Did you know over half of HIV-positive people in the world are female?
March 09 2026 6:47 PM
Why are Black people still the most affected by HIV criminalization?
February 27 2026 8:44 PM
What to know about HIV testing and treatment if you’re Black and LGBTQ+
February 24 2026 9:04 AM
6 Black activists who changed the HIV/AIDS response in America
February 09 2026 9:55 AM
National Black HIV/AIDS Awareness Day: a time for action on many fronts
February 07 2026 3:49 PM
Black Americans are disproportionately criminalized for living with HIV. Here's how
February 06 2026 4:26 PM
13 Black community organizations fighting HIV in the U.S. you should know
February 03 2026 10:45 AM
Meet the activist who wants people living with HIV to know they’re still sexy
January 28 2026 10:02 AM
An HIV breakthrough is here. Let's not let it go to waste
January 21 2026 12:40 PM
HIV-positive men stage 'Kiss-In' protest at U.S.-Mexico border
December 01 2025 12:56 PM
Trending stories
Recommended Stories for You































































